Regeneron Pharmaceuticals (REGN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Regeneron Pharmaceuticals (REGN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.20% |
| Dec 31, 2025 | -5.97% |
| Sep 30, 2025 | 11.63% |
| Jun 30, 2025 | 9.17% |
| Mar 31, 2025 | 5.30% |
| Dec 31, 2024 | 2.99% |
| Sep 30, 2024 | 14.89% |
| Jun 30, 2024 | 49.30% |
| Mar 31, 2024 | 9.38% |
| Dec 31, 2023 | 7.17% |
| Sep 30, 2023 | 11.13% |
| Jun 30, 2023 | 11.92% |
| Mar 31, 2023 | 11.34% |
| Dec 31, 2022 | 47.15% |
| Sep 30, 2022 | 27.64% |
| Jun 30, 2022 | 17.05% |
| Mar 31, 2022 | 31.36% |
| Dec 31, 2021 | 54.51% |
| Sep 30, 2021 | 43.87% |
| Jun 30, 2021 | 73.66% |